Show simple item record

Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

dc.contributor.authorRodríguez Carrio, Javier 
dc.contributor.authorBurska, A.
dc.contributor.authorConaghan, P. G.
dc.date.accessioned2023-06-26T09:03:33Z
dc.date.available2023-06-26T09:03:33Z
dc.date.issued2023
dc.identifier.citationRMD Open, 9(1) (2023); doi:10.1136/rmdopen-2022-002864
dc.identifier.issn2056-5933
dc.identifier.urihttp://hdl.handle.net/10651/68620
dc.description.sponsorshipEULAR [SCI019]; UK National Institute for Health and Care Research (NIHR) Leeds Biomedical Research Centre
dc.description.statementofresponsibilityRodríguez-Carrio J, Burska A, Conaghan PG, Dik WA, Biesen R, Eloranta ML, Cavalli G, Visser M, Boumpas DT, Bertsias G, Wahren-Herlenius M, Rehwinkel J, Frémond ML, Crow MK, Ronnblom L, Vital E, Versnel M
dc.language.isoeng
dc.relation.ispartofRMD Open
dc.rights© Author(s) (or their employer(s)) 2023
dc.rightsCC Reconocimiento 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85149596915&doi=10.1136%2frmdopen-2022-002864&partnerID=40&md5=ef2362b5cfc6f97372d57901ff25f67f
dc.titleAssociation between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
dc.typejournal article
dc.identifier.doi10.1136/rmdopen-2022-002864
dc.relation.publisherversionhttp://dx.doi.org/10.1136/rmdopen-2022-002864
dc.rights.accessRightsopen access
dc.type.hasVersionVoR


Files in this item

untranslated

This item appears in the following Collection(s)

Show simple item record

© Author(s) (or their
employer(s)) 2023
This item is protected with a Creative Commons License